Pharmx Technologies Limited (ASX: PHX), headquartered in Sydney, Australia, is a leading provider of electronic pharmacy ordering platforms across Australia and New Zealand. Founded in 1950, the company facilitates approximately $20 billion in orders annually, offering a high-availability technology platform that connects pharmacies, suppliers, and technology vendors. Pharmx focuses on streamlining pharmacy supply chains by providing real-time inventory management, eInvoicing, and analytics solutions. As a major player in pharma-tech, Pharmx is well-positioned for continued growth, driven by rising healthcare demand, regulatory changes, and digital transformation in the pharmaceutical industry. Currently, the company’s shares are trading at 8.3 cents per share.
Expanding Digital Integration in the Pharmacy Sector
Through its partnership with Toniq, Pharmx is expanding its digital footprint within New Zealand’s pharmacy sector. Toniq, a member of the global healthcare technology group Clanwilliam, is the dominant provider of pharmacy management software in New Zealand, supporting over 900 pharmacies with POS and dispensary solutions. By integrating Pharmx Gateway, Toniq customers will now have access to automated inventory ordering, real-time supplier connectivity, and seamless eInvoicing, reducing administrative workload and increasing operational efficiency.
This collaboration aligns with the broader digital transformation in healthcare, where automation and real-time data exchange are increasingly essential for improving supply chain efficiency. Pharmx’s platform is expected to enhance order accuracy, reduce manual processes, and provide more data-driven insights for both pharmacies and suppliers.
Increasing Operational Efficiency for Pharmacies and Suppliers
A key advantage of Pharmx Gateway is its ability to reduce the time-consuming manual processes that pharmacies and suppliers currently face. Pharmx estimates that its system saves pharmacies an average of 40 minutes per order, which over a year can equate to one full-time employee’s workload. On the supplier side, order processing time is reduced by approximately 15 minutes per transaction, streamlining workflows and improving overall efficiency.
With labour shortages and increasing demand for pharmaceutical services, the ability to free up staff time for patient care rather than administrative tasks is becoming a critical value driver for pharmacies. Pharmx’s technology offers a scalable solution that allows pharmacies to focus more on clinical services and patient outcomes, rather than supply chain logistics.
Strategic Importance of the New Zealand Market
Pharmx’s entry into the New Zealand market through Toniq represents a significant milestone in its expansion strategy. With this partnership, 99% of pharmacies across Australia and New Zealand will have access to Pharmx’s digital ordering and supplier connectivity solutions. This strengthens Pharmx’s position as the leading pharmacy ordering network in the ANZ region.
The New Zealand pharmaceutical sector is undergoing a digital transformation, and with Toniq’s established presence, Pharmx is well-positioned to become the primary electronic pharmacy ordering platform in the country. This not only enhances Pharmx’s existing market position but also provides growth opportunities through increased transaction volumes, additional supplier integrations, and future software enhancements.
Positioned for Growth in Healthcare Technology
With healthcare becoming increasingly reliant on digital solutions, Pharmx is at the forefront of modernising pharmacy supply chains through automation and connectivity. The company’s strategy is aligned with global trends in healthcare technology, where real-time data exchange, automation, and integrated platforms are becoming essential for industry efficiency.
The partnership with Toniq further strengthens Pharmx’s competitive advantage, providing pharmacies with seamless digital solutions and suppliers with improved transaction efficiencies. As the integration progresses, investors will be closely watching for increases in transaction volumes, new supplier partnerships, and further regional expansion opportunities that could drive Pharmx’s long-term growth and market dominance.
